{"transactions":[{"id":739714,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:45:41.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001272181-26-000006","document":"form4-06122026_090636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000127218126000006/form4-06122026_090636.xml","form_type":"4"}},{"id":749458,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257898/ownership.xml","form_type":"4"}},{"id":777562,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:08:02.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":3305,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2026, for no consideration."}],"balance_after":66622,"source":{"system":"sec-edgar","filing":"0001272181-26-000004","document":"wk-form4_1778875679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000127218126000004/wk-form4_1778875679.xml","form_type":"4"}},{"id":929037,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-29T01:30:12.000Z","date":"2026-01-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Arrangement Agreement in exchange for (i) $2.20 less the applicable exercise price in respect of such option plus (ii) one CVR per share underlying such option."}],"balance_after":0,"derivative":{"exercise_price":2.062,"expiration_date":"2029-03-29","underlying":"Common Shares","underlying_shares":37941},"source":{"system":"sec-edgar","filing":"0001272181-26-000002","document":"form4-01282026_080109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000127218126000002/form4-01282026_080109.xml","form_type":"4"}},{"id":929036,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-01-29T01:30:12.000Z","date":"2026-01-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to that certain Arrangement Agreement, dated November 14, 2025 (the \"Arrangement Agreement\"), by and between the Issuer and XenoTherapeutics, Inc. (the \"Parent\"), Xeno Acquisition Corp. (the \"Purchaser\"), and XOMA Royalty Corporation (\"XRC\"), in exchange for (i) $2.20 in cash per share, plus (ii) one non-transferable contingent value right (\"CVR\") per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Arrangement Agreement, the Purchaser acquired all of the issued and outstanding common shares of the Issuer for (i) $2.20 in cash per share plus (ii) one CVR per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001272181-26-000002","document":"form4-01282026_080109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000127218126000002/form4-01282026_080109.xml","form_type":"4"}},{"id":1113265,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:58:34.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016990","document":"form4-06122025_080630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016990/form4-06122025_080630.xml","form_type":"4"}},{"id":1119469,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:12.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083038/ownership.xml","form_type":"4"}},{"id":1143493,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:57:41.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5058,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 15, 2025 for no consideration."}],"balance_after":63317,"source":{"system":"sec-edgar","filing":"0001628280-25-026568","document":"wk-form4_1747688254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828025026568/wk-form4_1747688254.xml","form_type":"4"}},{"id":1473305,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:36:10.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":27200,"derivative":{"exercise_price":3.8,"expiration_date":"2034-06-16","underlying":"Common Shares","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001415889-24-017662","document":"form4-06202024_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000141588924017662/form4-06202024_080606.xml","form_type":"4"}},{"id":1475142,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T00:59:41.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 4 quarterly installments, commencing from June 13, 2024 until the one year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date."}],"balance_after":11333,"derivative":{"exercise_price":16.04,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001415889-24-017524","document":"form4-06192024_120638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924017524/form4-06192024_120638.xml","form_type":"4"}},{"id":1486605,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-06-07T20:30:05.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":26000,"derivative":{"exercise_price":21.79,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000950170-24-070699","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024070699/ownership.xml","form_type":"4"}},{"id":1516305,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T20:21:21.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":13162,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU was granted on May 13, 2024 for no consideration."}],"balance_after":58259,"source":{"system":"sec-edgar","filing":"0001628280-24-023569","document":"wk-form4_1715804469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828024023569/wk-form4_1715804469.xml","form_type":"4"}},{"id":1687698,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-01-04T22:37:38.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":32934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 12 quarterly installments over three years, commencing on January 2, 2024 and continuing thereafter on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date."}],"balance_after":32934,"derivative":{"exercise_price":11.01,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":32934},"source":{"system":"sec-edgar","filing":"0001209191-24-000861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919124000861/doc4.xml","form_type":"4"}},{"id":1858940,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T20:32:11.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":27200,"derivative":{"exercise_price":11.66,"expiration_date":"2033-06-07","underlying":"Common Shares","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001209191-23-036336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919123036336/doc4.xml","form_type":"4"}},{"id":1869496,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-06-02T21:00:19.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":26000,"derivative":{"exercise_price":13.32,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-033879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033879/doc4.xml","form_type":"4"}},{"id":1893844,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:25:53.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":13192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2023, for no consideration."}],"balance_after":45097,"source":{"system":"sec-edgar","filing":"0001628280-23-018209","document":"wf-form4_168418233227543.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000162828023018209/wf-form4_168418233227543.xml","form_type":"4"}},{"id":2221593,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T16:30:15.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2022 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 23, 2023 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":0.4561,"exercise_date":"2023-06-23","expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-22-006938","document":"form4-06272022_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922006938/form4-06272022_040601.xml","form_type":"4"}},{"id":2222966,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2022-06-23T20:53:12.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":14.84,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-038936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122038936/doc4.xml","form_type":"4"}},{"id":2270466,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T23:31:11.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":49000,"derivative":{"exercise_price":9.55,"expiration_date":"2032-05-13","underlying":"Common Shares","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001209191-22-029376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919122029376/doc4.xml","form_type":"4"}},{"id":2272389,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T22:15:31.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":14645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 11, 2022, for no consideration."}],"balance_after":31905,"source":{"system":"sec-edgar","filing":"0001140361-22-019178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122019178/form4.xml","form_type":"4"}},{"id":2657006,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-06-23T21:22:26.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":21.54,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-21-042792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121042792/doc4.xml","form_type":"4"}},{"id":2674653,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T17:05:28.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2021 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 8, 2022 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":1.31,"exercise_date":"2022-06-08","expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001415889-21-002915","document":"form4-06102021_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921002915/form4-06102021_050601.xml","form_type":"4"}},{"id":2680849,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-06-04T20:29:04.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments commencing on the one year anniversary of the date of grant."}],"balance_after":46000,"derivative":{"exercise_price":21.41,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001209191-21-038237","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121038237/doc4.xml","form_type":"4"}},{"id":2712534,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T20:51:10.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":21000,"derivative":{"exercise_price":32.44,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-21-032775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919121032775/doc4.xml","form_type":"4"}},{"id":2712672,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-14T20:35:50.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":7558,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2021 for no consideration."}],"balance_after":17260,"source":{"system":"sec-edgar","filing":"0001140361-21-017421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036121017421/form4.xml","form_type":"4"}},{"id":2745426,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:28:40.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of common stock of the Company, par value $0.001 per share (\"Common Stock\"), granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) $38.00 minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of common stock of the Company, par value $0.001 per share (\"Common Stock\"), granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) $38.00 minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":4.14,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-027405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027405/doc4.xml","form_type":"4"}},{"id":2745425,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:28:40.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of common stock of the Company, par value $0.001 per share (\"Common Stock\"), granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) $38.00 minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of common stock of the Company, par value $0.001 per share (\"Common Stock\"), granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) $38.00 minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":6.09,"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-027405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027405/doc4.xml","form_type":"4"}},{"id":2745424,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:28:40.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of common stock of the Company, par value $0.001 per share (\"Common Stock\"), granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) $38.00 minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of common stock of the Company, par value $0.001 per share (\"Common Stock\"), granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) $38.00 minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":9.17,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-027405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027405/doc4.xml","form_type":"4"}},{"id":2759457,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T16:30:53.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":11177,"price":1.32,"value":14753.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":59665,"source":{"system":"sec-edgar","filing":"0001415889-21-001879","document":"form4-04052021_040427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921001879/form4-04052021_040427.xml","form_type":"4"}},{"id":2917389,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T16:39:11.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":3620,"price":4.02,"value":14552.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":48488,"source":{"system":"sec-edgar","filing":"0001179110-21-000331","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911021000331/edgar.xml","form_type":"4"}},{"id":3014447,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T16:07:52.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":6111,"price":2.25,"value":13749.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":44868,"source":{"system":"sec-edgar","filing":"0001179110-20-010223","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020010223/edgar.xml","form_type":"4"}},{"id":3093801,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:59:48.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":7681,"price":1.79,"value":13748.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":38757,"source":{"system":"sec-edgar","filing":"0001179110-20-008008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020008008/edgar.xml","form_type":"4"}},{"id":3099919,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-06-25T21:58:07.000Z","date":"2020-06-23","kind":"purchase","acquired":true,"shares":8000,"price":20,"value":160000.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-20-038973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000120919120038973/doc4.xml","form_type":"4"}},{"id":3143939,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T19:08:50.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2020 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on May 12, 2021 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":1.97,"exercise_date":"2021-05-12","expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-20-006351","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020006351/edgar.xml","form_type":"4"}},{"id":3147497,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-15T17:33:39.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in its entirety on the earlier to occur of (i) May 14, 2021 or (ii) the day before the 2021 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the \"Company\"), subject to the reporting person's continued service to the Company through such vest date."}],"balance_after":20000,"derivative":{"exercise_price":4.14,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-029806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919120029806/doc4.xml","form_type":"4"}},{"id":3149272,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T01:00:31.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":8097,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on May 12, 2020 for no consideration."}],"balance_after":9702,"source":{"system":"sec-edgar","filing":"0001104659-20-061858","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920061858/a4.xml","form_type":"4"}},{"id":3184894,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T17:21:06.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":10633,"price":1.28,"value":13610.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":31076,"source":{"system":"sec-edgar","filing":"0001179110-20-004667","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911020004667/edgar.xml","form_type":"4"}},{"id":3187021,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T21:46:47.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":1605,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was granted on April 1, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock."}],"balance_after":1605,"source":{"system":"sec-edgar","filing":"0001104659-20-042576","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000110465920042576/a4.xml","form_type":"4"}},{"id":3401914,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:55:12.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":5098,"price":2.67,"value":13611.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":20443,"source":{"system":"sec-edgar","filing":"0001104659-19-052801","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000110465919052801/a4.xml","form_type":"4"}},{"id":3472976,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T16:38:16.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":5179,"price":2.61,"value":13517.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001179110-19-008387","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019008387/edgar.xml","form_type":"4"}},{"id":3492936,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T18:26:03.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in its entirety on the earlier to occur of (i) June 10, 2020 or (ii) the day before the 2020 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the \"Company\"), subject to the reporting person's continued service to the Company through such vest date."}],"balance_after":1250,"derivative":{"exercise_price":6.09,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-19-036510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919119036510/doc4.xml","form_type":"4"}},{"id":3499524,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:07:05.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2019 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in full and become immediately exercisable on June 4, 2020 (first anniversary of the date of grant), subject to continued service as a director of the Issuer."}],"balance_after":11500,"derivative":{"exercise_price":2.57,"exercise_date":"2020-06-04","expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001179110-19-007280","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019007280/edgar.xml","form_type":"4"}},{"id":3524028,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-16T18:42:28.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest at a rate of one-third per year on each anniversary of May 15, 2019, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through each such date."}],"balance_after":25000,"derivative":{"exercise_price":9.17,"expiration_date":"2029-05-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-030613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919119030613/doc4.xml","form_type":"4"}},{"id":3570412,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T17:17:08.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":5166,"price":2.59,"value":13379.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock was issued to the reporting person pursuant to her election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees."}],"balance_after":10166,"source":{"system":"sec-edgar","filing":"0001179110-19-004542","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019004542/edgar.xml","form_type":"4"}},{"id":3723901,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-20T17:25:09.000Z","date":"2018-12-18","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted under the Issuer's 2013 Stock Incentive Plan. The option vests and becomes exercisable over a three-year period commencing on December 18, 2018. Thirty-three percent (33%) of the underlying shares vest and become exercisable on December 18, 2019 (first anniversary of the date of grant) with the balance of the underlying shares vesting in eight equal quarterly installments over the remaining two years of the three-year period, subject to continued service with the Issuer. The option automatically becomes exercisable in full upon the occurrence of a change in control of the Issuer."}],"balance_after":23000,"derivative":{"exercise_price":3.12,"expiration_date":"2028-12-18","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001179110-18-014192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911018014192/edgar.xml","form_type":"4"}},{"id":3723900,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-20T17:25:09.000Z","date":"2018-12-19","kind":"purchase","acquired":true,"shares":5000,"price":3.3342,"value":16671.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $3.293 to $3.3705 per share. The reporting person hereby undertakes, upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001179110-18-014192","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911018014192/edgar.xml","form_type":"4"}}]}